ENTO-R-CHOP (FL)

ENTO-R-CHOP (FL)

Phase Ib - II Study of Entospletinib (ENTO) in Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL) Patients With aaIPI>=1 Treated by Rituximab, Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone (R-CHOP) (ENTO-R-CHOP)


Study treatments

Treatment:


Inclusion criteria


Exclusion criteria


Participating sites

Link